Rare actinomycetes: a potential storehouse for novel antibiotics

References

• Amann RI, Ludwig W, Schleifer K-H. (1995). Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev, 59, 143–169.
   PubMedGoogle Scholar
• Ashton C. (1999). Reinventing drug development. Chem Ind, 11, 422–425.
   Google Scholar
• Ausman DJ. (2001). Screening’s age of insecurity. Mod Drug Discovery, 4, 32–39.
   Google Scholar
• Baltz RH. (2005). Antibiotic discovery from actinomycetes: will a renaissance follow the decline and fall? SIM News, 55, 186–196.
   Google Scholar
• Baltz RH. (2006). Combinatorial biosynthesis of novel antibiotics and other secondary metabolites in actinomycetes. SIM News, 56, 148–160.
   Google Scholar
• Baltz RH. (2007). Antimicrobials from actinomycetes: back to the future. Microbe, 2, 125–131.
   Google Scholar
• Baltz RH. (2008). Renaissance in antibacterial discovery from actinomycetes. Curr Opin Pharmacol, 8, 557–563
   Google Scholar
• Bardone MR, Paternoster M, Coronelli C. (1978). Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. J Antibiot, 31, 170–177.
   PubMed Web of Science ®Google Scholar
• Beggs M, Long AC. (2002). High throughput genomics and drug discovery parallel universes or a continuum? Drug Discov World, 3, 75–80.
   Google Scholar
• Bentley SD, Chater KF, Cerdeno-Tarraga AM, Challis GL, Thomson NR, James KD, Harris DE, Quail MA, Kieser H, Harper D, Bateman A, Brown S, Chandra G, Chen CW, Collins M, Cronin A, Fraser A, Goble A, Hidalgo J, Hornsby T, Howarth S, Huang CH, Kieser T, Larke L, Murphy L, Oliver K, O’Neil S, Rabbinowitsch E, Rajandream MA, Rutherford K, Rutter S, Seeger K, Saunders D, Sharp S, Squares R, Squares S, Taylor K, Warren T, Wietzorrek A, Woodwardm J, Barrell BG, Parkhill J, Hopwood DA. (2002). Complete genome sequence of the model actinomycetes Streptomyces coelicolor A3(2). Nature, 417, 141–147.
   PubMed Web of Science ®Google Scholar
• Blunt JW, Copp BR, Hu V-P, Munro HG, Northcote PT, Prinsep MR. (2007). Marine natural products. Nat Prod Rep, 24, 31–86.
   PubMed Web of Science ®Google Scholar
• Bostian KA, Schmid MB. (1997). New Antibacterial Targets and New Approaches for Drug Discovery. In: Busse WD, Zeiler HJ, Labischinski H, eds. Antibacterial Therapy: Achievements, Problems and Future Perspectives. Berlin: Springer-Verlag, 61–68.
   Google Scholar
• Bredholt H, Fjaervik E, Johnsen G, Zotchev SB. (2008). Actinomycetes from sediments in the Trondheim Fjord, Norway: diversity and biological activity. Mar Drugs, 6, 12–24.
   PubMed Web of Science ®Google Scholar
• Broach JR, Thorner J. (1996). High-throughput screening for drug discovery. Nature, 384S, 14–16.
   Google Scholar
• Bulina TI, Alferova IV, Terekhova LP. (1997). A new method for the isolation of actinomycetes with the use of microwave irradiation of soil samples. Mikrobiologiya, 66, 278–282.
   Google Scholar
• Bulina TI, Terekhova LP, Tyurin MV. (1998). Use of electric pulses for isolation of actinomycetes from soil. Mikrobiologiya, 67, 556–560.
   Web of Science ®Google Scholar
• Bull AT, Stach JE. (2007). Marine actinobacteria: new opportunities for natural product search and discovery. Trends Microbiol, 15, 491–499.
   PubMed Web of Science ®Google Scholar
• Bull AT, Goodfellow M, Slater JH. (1992). Biodiversity as a source of innovation in biotechnology. Annu Rev Microbiol, 42, 219–257.
   Google Scholar
• Bull AT, Stach JEM, Ward AC, Goodfellow M. (2005). Marine actinobacteria: perspectives, challenges, future directions. Antonie van Leeuwenhoek, 87, 259–276.
   Web of Science ®Google Scholar
• Butler MS, Buss AD. (2006). Natural products—the future scaffolds for novel antibiotics? Biochem Pharmacol, 71, 919–929.
   PubMed Web of Science ®Google Scholar
• Cai Y, Xue Q, Chen Z, Zhang R. (2009). Classification and salt-tolerance of actinomycetes in the Qinghai Lake water and Lakeside saline soil. J Sustainable Dev, 2, 107–110.
   Google Scholar
• Cho SH, Hwang CW, Chung HK, Yang CS. (1994). A new medium for the selective isolation of soil actinomycetes. K J Appl Microbiol Biotechnol, 22, 561–563.
   Google Scholar
• Ciabatti R, Cavalleri B. (1989). Ramoplanin (A/16686): a new glycodepsipeptide antibiotic from Actinoplanes. Progr Ind Microbiol, 27, 205–219.
   Google Scholar
• Contag PR. (2002). Whole-animal cellular and molecular imaging to accelerate drug development. Drug Discov Today, 7, 555–562.
   PubMed Web of Science ®Google Scholar
• Cooper R, Das P, Federbush C, Mierzwa R, Patel M, Pramanik B, Truumees I. (1990). Characterization of peptidyl-nucleoside antifungal antibiotics from fermentation broth. J Ind Microbiol, 5, 1–8.
   PubMedGoogle Scholar
• Cutler P, Birrell H, Haran M, Man W, Neville B, Rosier S, Skehel M, White I. (1999). Proteomics in pharmaceutical research and development. Biochem Soc Trans, 27, 555–559.
   PubMed Web of Science ®Google Scholar
• Davies J. (1999). Millennium bugs. Trends Biochem Sci, 24, M2–M5
   Web of Science ®Google Scholar
• Demain AL. (2002). Prescription for an ailing pharmaceutical industry. Nat Biotechnol, 20, 331–334.
   PubMed Web of Science ®Google Scholar
• Donadio S, Monciardini P, Alduina R, Mazza P, Chiocchini C, Cavaletti L, Sosio M, Puglia A-M. (2002). Microbial technologies for the discovery of novel bioactive metabolites. J Biotechnol, 99, 187–198.
   Google Scholar
• Eccleston GP, Brooks PR, Kurtböke DI. (2008). The occurrence of bioactive micromonosporae in aquatic habitats of the Sunshine Coast in Australia. Mar Drugs, 6, 243–261.
   PubMed Web of Science ®Google Scholar
• Fenical W. (2006). Marine pharmaceuticals: past, present, and future. Oceanography, 19, 110–119.
   Google Scholar
• Fenical W, Jensen PR. (2006). Developing a new resource for drug discovery: marine actinomycete bacteria. Nat Chem Biol, 2, 666–673.
   PubMed Web of Science ®Google Scholar
• Fiedler HP, Bruntner C, Bull AT, Ward AC, Goodfellow M, Potterat O, Puder C, Mihm G. (2005). Marine actinomycetes as a source of novel secondary metabolites. Antonie van Leeuwenhoek, 87, 37–42.
   PubMed Web of Science ®Google Scholar
• Fleming JD, Nisbet LJ, Brewer SJ. (1982). Target Directed Antimicrobial Screens. In: Bu’lock JD, et al., ed. Bioactive Microbial Products: Search and Discovery. New York: Academic Press, 107–130.
   Google Scholar
• Galatenko OA, Terekhova LP, Preobrazhenskaya TP. (1990). The Application of Ultraviolet Irradiations to the Isolation of Rare Actinomycete Genera. In: Poisk Produtsentov Antibiotikov Sredi Aktinomitsetov Redkikh Rodov (Search for Antibiotic Producers Among Rare Actinomycete Genera). Golym: Alma-Ata, 29–35.
   Google Scholar
• Goldman MA. (2005). Digital drug discovery. Genome Biology, 6, 348–350.
   PubMedGoogle Scholar
• Goodfellow M. (1983). Ecology of actinomycetes. Annu Rev Microbiol, 37, 189–216.
   PubMed Web of Science ®Google Scholar
• Goodfellow M. (2010). Selective Isolation of Actinobacteria. In: Baltz RH, Davies J, Demain AL, eds. Manual of Industrial Microbiology and Biotechnology. Section 1: Isolation and Screening of Secondary Metabolites and Enzymes, Bull AT, Davies JE (section eds). Washington: ASM Press, 3, 13–27.
   Google Scholar
• Goodfellow M, Fiedler, H-P. (2010). A guide to successful bioprospecting: informed by actinobacterial systematics. Antonie van Leeuwenhoek, 98, 119–142.
   PubMed Web of Science ®Google Scholar
• Hamaki T, Suzuki M, Fudou R, Jojima Y, Kajiura T, Tabuchi A, Sen K, Shibai H. (2005). Isolation of novel bacteria and actinomycetes using soil-extract agar medium. J Biosci Bioeng, 99, 485–492.
   PubMed Web of Science ®Google Scholar
• Handelsman J. (2004). Soils—the Metagenomics Approach. In: Bull AT, ed. Microbial Diversity and Bioprospecting. Washington: ASM Press, 109–119.
   Google Scholar
• Hayakawa M. (2008). Studies on the isolation and distribution of rare actinomycetes in soil. Actinomycetologica, 22, 12–19.
   Google Scholar
• Hayakawa M, Nonomura H. (1987a). Efficacy of artificial humic acid as a selective nutrient in HV agar used for the isolation of soil actinomycetes. J Ferment Technol, 65, 609–616.
   Google Scholar
• Hayakawa M, Nonomura H. (1987b). Humic acid-vitamin agar, a new medium for the selective isolation of soil actinomycetes. J Ferment Technol, 65, 501–509.
   Google Scholar
• Hayakawa M, Tamura T, Nonomura H. (1991). Selective isolation of Actinoplanes and Dactylosporangium from soil by using gamma-collidine as the chemoattractant. J Ferment Bioeng, 72, 426–432.
   Google Scholar
• Hayakawa M, Kajiura T, Nonomura H. (1991a). New methods for the highly selective isolation of Streptosporangium and Dactylosporangium from soil. J Ferment Bioeng, 72, 327–333.
   Google Scholar
• Hayakawa M, Sadakata T, Kajiura T, Nonomura H. (1991b). New methods for the highly selective isolation of Micromonospora and Microbispora from soil. J Ferment Bioeng, 72, 320–326.
   Google Scholar
• Hayakawa M, Iino H, Takeuchi S, Yamazaki T. (1997). Application of a method incorporating treatment with Chloramine-T for the selective isolation of Streptosporangiaceae from soil. J Ferment Bioeng, 84, 599–602.
   Google Scholar
• Hertzberg RP. (1993). Whole cell assays in screening for biologically active substances. Curr Opin Biotechnol, 4, 80–84.
   PubMedGoogle Scholar
• Hill DC, Wrigley SK, Nisbet LJ. (1998). Novel screen methodologies for identification of new microbial metabolites with pharmacological activity. Adv Biochem Eng Biotechnol, 59, 75–121.
   Google Scholar
• Holtzel A, Kemter C, Metzger JW, Jung G, Groth I, Fritz T, Fiedler H-P. (1998). Biosynthetic capacities of actinomycetes. 10. Spirofungin, a new antifungal antibiotic from Streptomyces violaceusniger TU 4113. J Antibiot, 51, 699–707.
   PubMed Web of Science ®Google Scholar
• Ishikawa J. (2008). Genome analysis system for actinomycetes: development and application. Actinomycetologica, 22(2), 46–49.
   Google Scholar
• Iwai H, Takahashi Y. (1992). Selection of Microbial Sources of Bioactive Compounds. In: Omura S, ed. The Search for Bioactive Compounds from Microorganisms. New York: Springer-Verlag, 281–302.
   Google Scholar
• Kim CJ, Lee KH, Shimazu A, Kwon OS, Park DJ. (1995). Isolation of rare actinomycetes in various types of soil. K J Appl Microbiol Biotechnol, 23, 36–42.
   Google Scholar
• Kizuka M, Enokita R, Takahashi K, Okazaki T. (1997). Distribution of the actinomycetes in the Republic of South Africa investigated using a newly developed isolation method. Actinomycetologia, 11, 54–55.
   Google Scholar
• Klabunde T. (2006). Chemogenomic approaches to ligand design. In: Rognan D, ed. Ligand design for G protein-coupled receptors. Weinheim: Wiley-VCH.
   Google Scholar
• Klabunde T. (2007). Chemogenomic approaches to drug discovery: similar receptors bind similar ligands. Br J Pharmacol, 152, 5–7.
   PubMed Web of Science ®Google Scholar
• Lam KS. (2006). Discovery of novel metabolites from marine actinomycetes. Curr Opin Microbiol, 9, 245–251.
   PubMed Web of Science ®Google Scholar
• Lamari L, Zitouni A, Boudjella H, Badji B, Sabaou N, Lebrihi A, Lefebvre G, Seguin E, Tillequin F. (2002). New dithiolopyrrolone antibiotics from Saccharothrix sp. SA 233. I. Taxonomy, fermentation, isolation and biological activities. J Antibiot, 55, 696–701.
   PubMed Web of Science ®Google Scholar
• Lancini G, Lorenzetti R. (1993). Biotechnology of Antibiotics and other Bioactive Microbial Metabolites. New York, London: Plenum Press, 49–57.
   Google Scholar
• Lazzarini A, Cavaletti L, Toppo G, Marinelli F. (2001). Rare genera of actinomycetes as potential producers of new antibiotics. Antonie van Leeuwenhoek, 79, 399–405.
   PubMed Web of Science ®Google Scholar
• Lechevalier HA, Lechevalier MP. (1967). Biology of actinomycetes. Annu Rev Microbiol, 21, 71–100.
   PubMed Web of Science ®Google Scholar
• Li-Hua H, Qi-Ren L, Cheng-Lin J. (1996). Diversity of soil actinomycetes in Japan and China. Appl Environ Microbiol, 62, 244–248.
   PubMed Web of Science ®Google Scholar
• Li Yu. V, Terekhova LP, Gapochka MG. (2002a). Isolation of actinomycetes from soil using extremely high-frequency radiation. Mikrobiologiya, 71, 119–122.
   Web of Science ®Google Scholar
• Li Yu. V, Terekhova LP, Alferova IV, Gapochka MG. (2002b). The use of EHF radiation in different wavelength bands for the selective isolation of actinomycetes from soil. Biomed Radioelektron, 5, 20–24.
   Google Scholar
• Long PF, Wildman HG, Amphlett GE. (1994). The use of statistical models to predict the effects of pretreatments on the total viable counts of actinomycetes isolated from soil. Actinomycetes, 5, 1–8.
   Google Scholar
• Miquely E, Martin C, Hardisson C, Manzanal MB. (1993). Synchronous germination of Streptomyces antibioticus spores: tool for the analysis of hyphal growth in liquid. FEMS Microbiol Lett, 109, 123–300.
   PubMed Web of Science ®Google Scholar
• Mochalkin I, Miller JR, Narasimhan L, Thanabal V, Erdman P, Cox PB, Prasad JV, Lightle S, Huband MD, Stover CK. (2009). Discovery of antibacterial biotin carboxylase inhibitors by virtual screening and fragment-based approaches. ACS Chem Biol, 4, 397–399.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. (2007). Natural products as sources of new drugs over the last 25 years. J Nat Prod, 70, 461–477.
   PubMed Web of Science ®Google Scholar
• Nisbet LJ. (1982). Current strategies in the search for bioactive microbial metabolites. J Chem Technol Biotechnol, 32, 251–270.
   Web of Science ®Google Scholar
• Nolan RD, Cross T. (1988). Isolation and Screening of Actinomycetes. In: Goodfellow M, Williams ST, Mordarski M, eds. Actinomycetes in Biotechnology. London: Academic Press, 2–8.
   Google Scholar
• Nonomura H. (1988). Isolation, taxonomy and ecology of soil actinomycetes. Actinomycetologia, 3, 45–54.
   Google Scholar
• Okami B, Hotta AK. (1988). Search and Discovery of New Antibiotics. In: Goodfellow M, Williams ST, Mordarski M, ed. Actinomycetes in Biotechnology. Oxford: Pergamon Press, 33–67.
   Google Scholar
• Okoro CK, Brown R, Jones AL, Andrews BA, Asenjo JA, Goodfellow M, Bull AT. (2009). Diversity of culturable actinomycetes in hyper-arid soils of the Atacama Desert, Chile. Antonie van Leeuwenhoek, 95, 121–133.
   PubMed Web of Science ®Google Scholar
• Omura S, Ikeda H, Ishikawa J, Hanamoto A, Takahashi C, Shinose M, Takahashi Y, Horikawa H, Nakazawa H, Osonoe T, Kikuchi H, Shiba T, Sakaki Y, Hattori M. (2001). Genome sequence of an industrial microorganism Streptomyces avermitilis: deducing the ability of producing secondary metabolites. Proc Natl Acad Sci USA, 98, 12215–12220.
   PubMed Web of Science ®Google Scholar
• O’Shea R, Moser HE. (2008). Physicochemical properties of antibacterial compounds: implications for drug discovery. J Med Chem, 51, 2871–8.
   PubMed Web of Science ®Google Scholar
• Palleroni NJ. (1980). A chemotactic method for the isolation of Actinoplanaceae. Arch Microbiol, 128, 53–55.
   Web of Science ®Google Scholar
• Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. (2007). Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov, 6, 29–40.
   PubMed Web of Science ®Google Scholar
• Perić-Concha Natasa Long, PF. (2003). Mining the microbial metabolome: a new frontier for natural product lead discovery. Drug Discov Today, 8, 1078–1084.
   PubMed Web of Science ®Google Scholar
• Pfefferle C, Theobald U, Gürtler H, Fiedler H-P. (2000). Improved secondary metabolite production in the genus Streptosporangium by optimization of the fermentation conditions. J Biotechnol, 80, 135–142.
   PubMed Web of Science ®Google Scholar
• Roda A, Guardigli M, Pasini P, Mirasoli M. (2003). Bioluminescence and chemiluminescence in drug screening. Anal Bioanal Chem, 377, 826–833.
   PubMed Web of Science ®Google Scholar
• Sabaou N, Boudjella H, Bennadji A, Mostefaoui A, Zitouni A, Lamari L, Bennadji H. (1998). Les sols des oasis du Sahara algérien, source d’actinomycètes rares producteurs d’antibiotiques. Sécheresse, 9, 147–153.
   Google Scholar
• Scherlach K, Hertweck C. (2009). Triggering cryptic natural product biosynthesis in microorganisms. Org Biomol Chem, 7, 1753–1760.
   PubMed Web of Science ®Google Scholar
• Schloss PD, Handelsman J. (2005). Metagenomics for studying unculturable microorganisms: cutting the Gordian knot. Genome Biol, 6, 229–232.
   PubMed Web of Science ®Google Scholar
• Singh SB, Barrett JF. (2006). Empirical antibacterial drug discovery-foundation in natural products. Biochem Pharmacol, 71, 1006–15.
   PubMed Web of Science ®Google Scholar
• Sogin ML, Morrison HG, Huber JA, Welch DM, Huse SM, Neal PR, Arrieta JM, Herndl GJ. (2006). Microbial diversity in the deep sea and the underexplored “rare biosphere”. Proc Natl Acad Sci U S A, 103, 12115–12120.
   PubMed Web of Science ®Google Scholar
• Sosio M, Bossi E, Bianchi A, Donadio S. (2000). Multiple peptide synthetase gene clusters in actinomycetes. Mol Gen Genet, 264, 213–221.
   PubMedGoogle Scholar
• Stach JEM, Bull AT. (2005). Estimating and comparing the diversity of marine actinobacteria. Antonie Van Leeuwenhoek, 87, 3–9.
   PubMed Web of Science ®Google Scholar
• Steffan RJ, Goskøyr J, Bej AK, Atlas RM. (1988). Recovery of DNA from soil and sediments. Appl Environ Microbiol, 54, 2908–2915.
   PubMed Web of Science ®Google Scholar
• Tishkov S. (2001). Bioactive Products from Actinomycetes–antibiotics, Enzyme Inhibitors, Immunomodulators. In: Moncheva P, Tishkov S, Chipeva V, ed. Innovative Aspects in Biotechnology of Prokaryotes. Sofia: National bank for industrial microorganisms and cell cultures, 111–138.
   Google Scholar
• Tomoda H, Omura S. (1990). New strategy for discovery of enzyme inhibitors: screening with intact mammalian cells or intact microorganisms having special functions. J Antibiot, 43, 1207–1223.
   PubMed Web of Science ®Google Scholar
• Umezawa H. (1982). Low molecular-weight enzyme inhibitors of microbial origin. Annu Rev Microbiol, 36, 75–99.
   PubMed Web of Science ®Google Scholar
• Walters WP, Namchuk M. (2003). Designing screens: how to make your hits a hit. Nat Rev Drug Discov, 2, 259–266.
   PubMed Web of Science ®Google Scholar
• Ward DM, Weller R, Bateson MM. (1990). 16S rRNA sequences reveal numerous uncultured microorganisms in a natural community. Nature, 345, 63–65.
   PubMed Web of Science ®Google Scholar
• Watve MG, Shejval V, Sonawane C, Rahalkar M, Matapurkar M, Shouche Y, Patole M, Phadnis N, Champhekar A, Damle K, Karandikar S, Kshirsagar V, Jog M. (2000). The ‘K’ selected oligophilic bacteria: a key to uncultured diversity? Curr Sci, 78, 1535–1542.
   Web of Science ®Google Scholar
• Watve G, Tickoo R, Jog MM, Bhole BD. (2001). How many antibiotics are produced by the genus Streptomyces? Arch Microbiol, 176, 391–392.
   Web of Science ®Google Scholar
• Weinbauer MG, Beckmann C, Hofle MG. (1998). Utility of green fluorescent nucleic acid dyes and aluminum oxide membrane filters for rapid epifluorescence enumeration of soil and sediment bacteria. Appl Environ Microbiol, 64, 5000–5003.
   PubMed Web of Science ®Google Scholar
• Wermuth CG. (2004). Selective optimization of side affinities: another way for drug discovery. J Med Chem, 47, 1303–1314.
   PubMed Web of Science ®Google Scholar
• Williams ST, Wellington EMH. (1982). Principles and problems of selective isolation of microbes. In: Bu’lock JD, Nisbet LJ, Winstanley DJ, ed. Bioactive microbial products: search and discovery. London: Academic Press, 9–26.
   Google Scholar
• Zazopoulos E, Huang K, Staffa A, Liu W, Bachmann BO, Nonaka K, Ahlert J, Thorson JS, Shen B, Farnet CM. (2003). A genomics-guided approach for discovering and expressing cryptic metabolic pathways. Nat Biotechnol, 21, 187– 190.
   PubMed Web of Science ®Google Scholar
• Zengler K, Walcher M, Clark G, Haller I, Toledo G, Holland T, Mathur EJ, Woodnutt G, Short JM, Keller M. (2005). High-throughput cultivation of microorganisms using microcapsules. Methods Enzymol, 397, 124–130.
   PubMed Web of Science ®Google Scholar
• Zinder SH. (2002). The future for culturing environmental organisms: a golden era ahead? Environ Microbiol, 4, 14–15.
   PubMed Web of Science ®Google Scholar
• Zitouni A, Boudjella H, Mathieu F, Sabaou N, Lebrihi A. (2004a). Mutactimycin PR, a new anthracycline antibiotic from Saccharothrix sp. SA 103. I. Taxonomy, fermentation, isolation and biological activities. J Antibiot, 57, 367–372.
   PubMed Web of Science ®Google Scholar
• Zitouni A, Lamari L, Boudjella H, Badji B, Sabaou N, Gaouar A, Mathieu F, Lebrihi A, Labeda DP. (2004b). Saccharothrix algeriensis sp. nov., isolated from Saharan soil. Int J Syst Evol Microbiol, 54, 1377–1381.
   PubMed Web of Science ®Google Scholar